High Court’s Tariff Ruling Likely Won’t Affect Deals Struck With Drugmakers
The Trump administration may impose sector-specific tariffs if pharmaceutical companies stray from most-favored-nation pricing for prescriptions, Managed Healthcare Executive reported. The administration is also looking at other statutes that would allow the use of tariffs to further its policy priorities.